FDA NDC Directory · JSON-LD · Markdown

TRODELVY

NDC 55135-132 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SOLUTION

Generic nameSACITUZUMAB GOVITECAN
Labeler / ManufacturerGilead Sciences, Inc.
Marketing categoryBiologic License Application · App BLA761115
Dosage form / routePOWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsSACITUZUMAB GOVITECAN (180 mg/1)
Marketing started20200422
Package count1

External sources

Source: openFDA. Public-domain (CC0).